第1阶段的VH4524184的评估,这是第三代整合酶链转移抑制剂,具有增强的阻力配置
Luise Rogg1, Mark Underwood1, Nathan Hanan2
1ViiV Healthcare, Durham, NC, USA.
概括
新型整合酶链转移抑制剂 (INSTI) VH-184显示出有利的安全性和长效潜力,可用于HIV-1治疗. 它保留了对抗耐药菌株的活性,支持其进一步发展.
科学领域:
- 开发抗病毒药物的开发.
- 艾滋病毒-1治疗药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 整合酶链转移抑制剂 (INSTIs) 对于HIV-1治疗至关重要.
- VH4524184 (VH-184) 是一个有前途的第三代INSTI,具有长效的潜力.
研究的目的:
- 评估口服VH-184的安全性,耐受性和药理动力学,在首次对人体进行的研究中.
- 为了评估VH-184的体外耐药性概况与INSTI耐药性HIV-1菌株.
主要方法:
- 第1期,双盲,随机,安慰剂对照研究,单剂和多剂VH-184的上升剂量.
- 药物动力学评估,包括药物相互作用与米达佐拉姆和食物的影响.
- 在体外评估VH-184对具有耐药性突变的伪型病毒.
主要成果:
- 在不同剂量范围内,VH-184表现出良好的安全性和耐受性.
- 观察到高达300毫克的剂量比例的药理动力学,其半衰期约为24小时.
- VH-184对第二代INSTI耐药HIV-1菌株保持了抗病毒活性.
结论:
- 该研究支持VH-184.4的安全性和进一步发展.
- VH-184显示出作为一种长效的第三代INSTI治疗HIV-1的潜力.
相关概念视频
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


